The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.

Summary from the MarketWatch news feed. Copyright belongs to MarketWatch.

Opens in a new tab, so Investz stays open.

ShareEmail X LinkedIn Facebook Reddit WhatsApp

More headlines

CNBCDow tumbles more than 600 points as oil prices rise and market sell-off hits most sectors: Live updates MarketWatchMy spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair?CNBCTrump's executive order targets mortgage insurance, refinance costs. What it means for borrowers CNBCMusk's SpaceX is still restricting Starlink in Ukraine and the toll is rising MarketWatchEven the wealthy increasingly want all-inclusive resorts CNBCInvestors are starting to find opportunities in the battered bond market

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.